PA
RNAM

Profund Advisors’s Avidity Biosciences RNAM Stock Holding History

Profund Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,642
Closed -$2.28M – 1261
2025
Q4 		$2.28M Sell
31,642
-6,012
-16% -$388K 0.07% 190
2025
Q3 		$1.64M Buy
37,654
+10,330
+38% +$418K 0.05% 229
2025
Q2 		$776K Sell
27,324
-3,450
-11% -$103K 0.03% 358
2025
Q1 		$908K Sell
30,774
-4,207
-12% -$131K 0.04% 313
2024
Q4 		$1.02M Sell
34,981
-4,990
-12% -$209K 0.04% 291
2024
Q3 		$1.84M Buy
39,971
+18,545
+87% +$805K 0.07% 203
2024
Q2 		$875K Sell
21,426
-10,627
-33% -$305K 0.03% 334
2024
Q1 		$818K Sell
32,053
-707
-2% -$11.1K 0.03% 409
2023
Q4 		$296K Sell
32,760
-22,961
-41% -$153K 0.01% 789
2023
Q3 		$356K Sell
55,721
-42,984
-44% -$370K 0.02% 581
2023
Q2 		$1.09M Buy
98,705
+41,340
+72% +$519K 0.06% 297
2023
Q1 		$881K Buy
+57,365
New +$1.26M 0.05% 330

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Profund Advisors's RNAM Position: Q1 2026 in Review

Profund Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 31,642 shares — an estimated $2.28M sold.

Profund Advisors first reported a position in RNAM in Q1 2023 and held it in 12 quarters. The position peaked at $2.28M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Profund Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Profund Advisors sold 31,642 Avidity Biosciences shares in Q1 2026, an estimated $2.28M.
  • Profund Advisors first reported a position in Avidity Biosciences in Q1 2023 and held it in 12 quarters.
  • Profund Advisors's Avidity Biosciences position peaked at $2.28M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.